Insider trades
Evan Lippman, EVP of Teva Pharmaceutical Industries TEVA, has filed 0 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $1.5M. The latest trade was on 05/14.
Evan Lippman
EVP, Business Development
- First filing
- 25/05/19
- Trades
- 9 trades
- Buys / sales
- 0 / 2
- 12-month net buying
- −$1.5M
- Last trade
- 05/14
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
TEVA | Open-market sale10b5-1 plan | 05/14 | 05/18 | 41,658 sh2 trades | $35.58avg. | $1,482,191.64 | −48.5% |